{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T09:09:45Z","timestamp":1788772185005,"version":"build-2803163510"},"reference-count":29,"publisher":"S.C. JURNALUL PENTRU MEDICINA SI VIATA S.R.L","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.25122\/jml-2026-0050","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T08:34:15Z","timestamp":1788770055000},"page":"406-416","source":"Crossref","is-referenced-by-count":0,"title":["Integrated clinico-radio-molecular profiling of diffuse gliomas across age groups: a Romanian single-center cohort study"],"prefix":"10.25122","volume":"19","author":[{"given":"Teodor Cristian","family":"Blidaru","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Carol Davila University of Medicine and Pharmacy, Bucharest, Romania","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Mitrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Neuroaxis Neurology Clinic, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Ghica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Carol Davila University of Medicine and Pharmacy, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius Cristian","family":"Zaharia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Carol Davila University of Medicine and Pharmacy, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Blidaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Carol Davila University of Medicine and Pharmacy, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria S\u00eenziana","family":"Matei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Carol Davila University of Medicine and Pharmacy, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raluca Maria","family":"Marin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Carol Davila University of Medicine and Pharmacy, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioana Raluca","family":"Papacocea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Carol Davila University of Medicine and Pharmacy, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10755","reference":[{"issue":"3","key":"ref1","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41571-020-00447-z","article-title":"EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood","volume":"18","author":"Weller M, van den Bent M, Preusser M, Le Rhun E, Tonn JC, Minniti G","year":"2021","unstructured":"1. Weller M, van den Bent M, Preusser M, Le Rhun E, Tonn JC, Minniti G, EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood, Nat Rev Clin Oncol, 2021;18(3):170-86","journal-title":"Nat Rev Clin Oncol"},{"issue":"8","key":"ref2","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO Classification of Tumors of the Central Nervous System: a summary","volume":"23","author":"Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D","year":"2021","unstructured":"2. Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, The 2021 WHO Classification of Tumors of the Central Nervous System: a summary, Neuro-Oncol, 2021;23(8):1231-51","journal-title":"Neuro-Oncol"},{"issue":"10","key":"ref3","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJB","year":"2005","unstructured":"3. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJB, Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma, N Engl J Med, 2005;352(10):987-96","journal-title":"N Engl J Med"},{"issue":"12","key":"ref4","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/noad149","article-title":"CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2016-2020","volume":"25","author":"Ostrom QT, Price M, Neff C, Cioffi G, Waite KA, Kruchko C","year":"2023","unstructured":"4. Ostrom QT, Price M, Neff C, Cioffi G, Waite KA, Kruchko C, CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2016-2020, Neuro-Oncol, 2023;25(12 Suppl 2):iv1-iv99","journal-title":"Neuro-Oncol"},{"issue":"11","key":"ref5","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1056\/NEJMoa1611977","article-title":"Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma","volume":"376","author":"Perry JR, Laperriere N, O\u2019Callaghan CJ, Brandes AA, Menten J, Phillips C","year":"2017","unstructured":"5. Perry JR, Laperriere N, O\u2019Callaghan CJ, Brandes AA, Menten J, Phillips C, Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma, N Engl J Med, 2017;376(11):1027-37","journal-title":"N Engl J Med"},{"issue":"4","key":"ref6","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.crad.2004.09.009","article-title":"High-grade and low-grade gliomas: differentiation by using perfusion MR imaging","volume":"60","author":"Hakyemez B, Erdogan C, Ercan I, Ergin N, Uysal S, Atahan S","year":"2005","unstructured":"6. Hakyemez B, Erdogan C, Ercan I, Ergin N, Uysal S, Atahan S, High-grade and low-grade gliomas: differentiation by using perfusion MR imaging, Clin Radiol, 2005;60(4):493-502","journal-title":"Clin Radiol"},{"issue":"2","key":"ref7","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1148\/radiol.2382042180","article-title":"Low-grade gliomas: dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging--prediction of patient clinical response","volume":"238","author":"Law M, Oh S, Babb JS, Wang E, Inglese M, Zagzag D","year":"2006","unstructured":"7. Law M, Oh S, Babb JS, Wang E, Inglese M, Zagzag D, Low-grade gliomas: dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging--prediction of patient clinical response, Radiology, 2006;238(2):658-67","journal-title":"Radiology"},{"issue":"1","key":"ref8","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","article-title":"Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1","volume":"17","author":"Verhaak RGW, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD","year":"2010","unstructured":"8. Verhaak RGW, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1, Cancer Cell, 2010;17(1):98-110","journal-title":"Cancer Cell"},{"issue":"26","key":"ref9","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1056\/NEJMoa1402121","article-title":"Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas","volume":"372","author":"Brat DJ, Verhaak RGW, Aldape KD, Yung WKA, Salama SR, Cancer Genome Atlas Research Network","year":"2015","unstructured":"9. Brat DJ, Verhaak RGW, Aldape KD, Yung WKA, Salama SR, Cancer Genome Atlas Research Network, Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas, N Engl J Med, 2015;372(26):2481-98","journal-title":"N Engl J Med"},{"issue":"4","key":"ref10","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nrc3245","article-title":"The immune contexture in human tumours: impact on clinical outcome","volume":"12","author":"Fridman WH, Pag\u00e8s F, Saut\u00e8s-Fridman C, Galon J","year":"2012","unstructured":"10. Fridman WH, Pag\u00e8s F, Saut\u00e8s-Fridman C, Galon J, The immune contexture in human tumours: impact on clinical outcome, Nat Rev Cancer, 2012;12(4):298-306","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"ref11","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.jgo.2019.11.001","article-title":"Decreasing incidence of upper age restriction enrollment criteria among cancer clinical trials","volume":"11","author":"Ludmir EB, Subbiah IM, Mainwaring W, Miller AB, Lin TA, Jethanandani A","year":"2020","unstructured":"11. Ludmir EB, Subbiah IM, Mainwaring W, Miller AB, Lin TA, Jethanandani A, Decreasing incidence of upper age restriction enrollment criteria among cancer clinical trials, J Geriatr Oncol, 2020;11(3):451-4","journal-title":"J Geriatr Oncol"},{"issue":"5","key":"ref12","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41571-019-0167-7","article-title":"Real-world data: towards achieving the achievable in cancer care","volume":"16","author":"Booth CM, Karim S, Mackillop WJ","year":"2019","unstructured":"12. Booth CM, Karim S, Mackillop WJ, Real-world data: towards achieving the achievable in cancer care, Nat Rev Clin Oncol, 2019;16(5):312-25","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"ref13","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s11060-026-05436-3","article-title":"Socioeconomic disparities in glioma outcomes: a grade-specific analysis","volume":"176","author":"Hon JJ, Akbarzadeh Mostaghbal H, Akkara Y, Das JM","year":"2026","unstructured":"13. Hon JJ, Akbarzadeh Mostaghbal H, Akkara Y, Das JM, Socioeconomic disparities in glioma outcomes: a grade-specific analysis, J Neurooncol, 2026;176(3):195","journal-title":"J Neurooncol"},{"issue":"7","key":"ref14","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.jval.2017.03.008","article-title":"What Is Real-World Data? A Review of Definitions Based on Literature and Stakeholder Interviews","volume":"20","author":"Makady A, de Boer A, Hillege H, Klungel O, Goettsch W, GetReal Work Package 1","year":"2017","unstructured":"14. Makady A, de Boer A, Hillege H, Klungel O, Goettsch W, GetReal Work Package 1, What Is Real-World Data? A Review of Definitions Based on Literature and Stakeholder Interviews, Value Health, 2017;20(7):858-65","journal-title":"Value Health"},{"issue":"4","key":"ref15","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP","year":"2008","unstructured":"15. von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP, STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies, J Clin Epidemiol, 2008;61(4):344-9","journal-title":"J Clin Epidemiol"},{"issue":"20","key":"ref16","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"310","author":"World Medical Association","year":"2013","unstructured":"16. World Medical Association, World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects, JAMA, 2013;310(20):2191-4","journal-title":"JAMA"},{"issue":"3","key":"ref17","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.cell.2015.12.028","article-title":"Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma","volume":"164","author":"Ceccarelli M, Barthel FP, Malta TM, Sabedot TS, Salama SR, Murray BA","year":"2016","unstructured":"17. Ceccarelli M, Barthel FP, Malta TM, Sabedot TS, Salama SR, Murray BA, Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma, Cell, 2016;164(3):550-63","journal-title":"Cell"},{"issue":"4","key":"ref18","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.3390\/curroncol28040220","article-title":"Outcomes in Elderly Patients with Glioblastoma Multiforme Treated with Short-Course Radiation Alone Compared to Short-Course Radiation and Concurrent and Adjuvant Temozolomide Based on Performance Status and Extent of Resection","volume":"28","author":"Mir T, Pond G, Greenspoon JN","year":"2021","unstructured":"18. Mir T, Pond G, Greenspoon JN, Outcomes in Elderly Patients with Glioblastoma Multiforme Treated with Short-Course Radiation Alone Compared to Short-Course Radiation and Concurrent and Adjuvant Temozolomide Based on Performance Status and Extent of Resection, Curr Oncol, 2021;28(4):2399-408","journal-title":"Curr Oncol"},{"issue":"3","key":"ref19","doi-asserted-by":"publisher","first-page":"336","DOI":"10.3390\/cancers11030336","article-title":"Glioblastoma in Elderly Patients: Current Management and Future Perspectives","volume":"11","author":"Minniti G, Lombardi G, Paolini S","year":"2019","unstructured":"19. Minniti G, Lombardi G, Paolini S, Glioblastoma in Elderly Patients: Current Management and Future Perspectives, Cancers, 2019;11(3):336","journal-title":"Cancers"},{"issue":"7390","key":"ref20","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/nature10866","article-title":"IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype","volume":"483","author":"Turcan S, Rohle D, Goenka A, Walsh LA, Fang F, Yilmaz E","year":"2012","unstructured":"20. Turcan S, Rohle D, Goenka A, Walsh LA, Fang F, Yilmaz E, IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype, Nature, 2012;483(7390):479-83","journal-title":"Nature"},{"issue":"5","key":"ref21","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.ccr.2010.03.017","article-title":"Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma","volume":"17","author":"Noushmehr H, Weisenberger DJ, Diefes K, Phillips HS, Pujara K, Berman BP","year":"2010","unstructured":"21. Noushmehr H, Weisenberger DJ, Diefes K, Phillips HS, Pujara K, Berman BP, Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma, Cancer Cell, 2010;17(5):510-22","journal-title":"Cancer Cell"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"ii7","DOI":"10.1093\/neuonc\/noab180.022","article-title":"OS05.5.A Methylation analysis of matched primary and recurrent IDHmt astrocytoma; an update from the Glioma Longitudinal Analysis NL (GLASS-NL) consortium","volume":"23","author":"Vallentgoed WR, Niers JM, van den Bent MJ, Kouwenhoven MCM, Kros JM, Martin I","year":"2021","unstructured":"22. Vallentgoed WR, Niers JM, van den Bent MJ, Kouwenhoven MCM, Kros JM, Martin I, OS05.5.A Methylation analysis of matched primary and recurrent IDHmt astrocytoma; an update from the Glioma Longitudinal Analysis NL (GLASS-NL) consortium, Neuro-Oncol, 2021;23(Suppl 2):ii7-8","journal-title":"Neuro-Oncol"},{"issue":"26","key":"ref23","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1056\/NEJMoa1407279","article-title":"Glioma Groups Based on 1p\/19q, IDH, and TERT Promoter Mutations in Tumors","volume":"372","author":"Eckel-Passow JE, Lachance DH, Molinaro AM, Walsh KM, Decker PA, Sicotte H","year":"2015","unstructured":"23. Eckel-Passow JE, Lachance DH, Molinaro AM, Walsh KM, Decker PA, Sicotte H, Glioma Groups Based on 1p\/19q, IDH, and TERT Promoter Mutations in Tumors, N Engl J Med, 2015;372(26):2499-508","journal-title":"N Engl J Med"},{"issue":"10","key":"ref24","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1056\/NEJMoa043331","article-title":"MGMT gene silencing and benefit from temozolomide in glioblastoma","volume":"352","author":"Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M","year":"2005","unstructured":"24. Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, MGMT gene silencing and benefit from temozolomide in glioblastoma, N Engl J Med, 2005;352(10):997-1003","journal-title":"N Engl J Med"},{"issue":"4","key":"ref25","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/nop\/npv037","article-title":"Response Assessment in Neuro-Oncology (RANO): more than imaging criteria for malignant glioma","volume":"2","author":"Chang SM, Wen PY, Vogelbaum MA, Macdonald DR, van den Bent MJ","year":"2015","unstructured":"25. Chang SM, Wen PY, Vogelbaum MA, Macdonald DR, van den Bent MJ, Response Assessment in Neuro-Oncology (RANO): more than imaging criteria for malignant glioma, Neuro-Oncol Pract, 2015;2(4):205-9","journal-title":"Neuro-Oncol Pract"},{"issue":"4","key":"ref26","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3322\/caac.21613","article-title":"Management of glioblastoma: State of the art and future directions","volume":"70","author":"Tan AC, Ashley DM, L\u00f3pez GY, Malinzak M, Friedman HS, Khasraw M","year":"2020","unstructured":"26. Tan AC, Ashley DM, L\u00f3pez GY, Malinzak M, Friedman HS, Khasraw M, Management of glioblastoma: State of the art and future directions, CA Cancer J Clin, 2020;70(4):299-312","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"ref27","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3390\/cancers17010146","article-title":"Glioblastoma: Clinical Presentation, Multidisciplinary Management, and Long-Term Outcomes","volume":"17","author":"Sipos D, Raposa BL, Freihat O, Simon M, Mekis N, Cornacchione P","year":"2025","unstructured":"27. Sipos D, Raposa BL, Freihat O, Simon M, Mekis N, Cornacchione P, Glioblastoma: Clinical Presentation, Multidisciplinary Management, and Long-Term Outcomes, Cancers, 2025;17(1):146","journal-title":"Cancers"},{"issue":"9","key":"ref28","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1093\/neuonc\/noab105","article-title":"MGMT promoter methylation testing to predict overall survival in people with glioblastoma treated with temozolomide: a comprehensive meta-analysis based on a Cochrane Systematic Review","volume":"23","author":"Brandner S, McAleenan A, Kelly C, Spiga F, Cheng HY, Dawson S","year":"2021","unstructured":"28. Brandner S, McAleenan A, Kelly C, Spiga F, Cheng HY, Dawson S, MGMT promoter methylation testing to predict overall survival in people with glioblastoma treated with temozolomide: a comprehensive meta-analysis based on a Cochrane Systematic Review, Neuro-Oncol, 2021;23(9):1457-69","journal-title":"Neuro-Oncol"},{"issue":"17","key":"ref29","doi-asserted-by":"publisher","first-page":"9714","DOI":"10.3390\/ijms25179714","article-title":"Molecular Profile as an Outcome Predictor in Glioblastoma along with MRI Features and Surgical Resection: A Scoping Review","volume":"25","author":"Papacocea SI, Vrinceanu D, Dumitru M, Manole F, Serboiu C, Papacocea MT","year":"2024","unstructured":"29. Papacocea SI, Vrinceanu D, Dumitru M, Manole F, Serboiu C, Papacocea MT, Molecular Profile as an Outcome Predictor in Glioblastoma along with MRI Features and Surgical Resection: A Scoping Review, Int J Mol Sci, 2024;25(17):9714","journal-title":"Int J Mol Sci"}],"container-title":["Journal of Medicine and Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/medandlife.org\/all-issues\/2026\/issue-5-2026\/original-article-issue-5-2026\/integrated-clinico-radio-molecular-profiling-of-diffuse-gliomas-across-age-groups-a-romanian-single-center-cohort-study\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T08:34:28Z","timestamp":1788770068000},"score":1,"resource":{"primary":{"URL":"https:\/\/medandlife.org\/all-issues\/2026\/issue-5-2026\/original-article-issue-5-2026\/integrated-clinico-radio-molecular-profiling-of-diffuse-gliomas-across-age-groups-a-romanian-single-center-cohort-study\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["JMedLife-19-406"],"URL":"https:\/\/doi.org\/10.25122\/jml-2026-0050","relation":{},"ISSN":["1844-3117"],"issn-type":[{"value":"1844-3117","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]}}}